Bispecific Antibodies Deliver One-Two Punch to Non-Hodgkin Lymphoma

×
NOW
PLAYING
CAR T-Cell Therapy: What You Should Know About Side Effects
NOW
PLAYING
Why CAR T-Cell Therapy Is So Exciting
NOW
PLAYING
Could New Non-Hodgkin Lymphoma Drugs Mean Less Chemo in the Future?
NOW
PLAYING
CAR T-Cell Therapy: What It’s Like to Get This Groundbreaking New Cancer Treatment
NOW
PLAYING
CAR-T Cell Therapy: A "Revolution" in Cancer Treatment
NOW
PLAYING
The Promise - and Risks - of CAR T-Cell Therapy

SurvivorNetTV.
Hope. Science.
Inspiration.

Discover SNTV

Recurrence: Options After Diffuse Large B-Cell Lymphoma Recurrence

SEE MORE   

Recurrence: Options After Diffuse Large B-Cell Lymphoma Recurrence

  • There are several treatment options available if non-Hodgkin lymphoma returns
  • The most common first treatment after relapse is another round of chemotherapy
  • For patients whose cancer does not respond well to chemo, doctors may explore immune-therapies such as CAR-T therapy
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.